image: Meeting Information
Credit: Keystone Symposia
NOVEMBER 5, 2026, NEW YORK – The Ludwig Institute for Cancer Research and Keystone Symposia announce a joint meeting, titled Tumor and Host Metabolism: Integrating, Molecular Cellular and Systemic Interactions, to be hosted by the Ludwig Institute’s Branch at Princeton University on March 7-10, 2027.
The meeting is being organized by Marcia Haigis of the Ludwig Center at Harvard University and Lydia Lynch of the Ludwig Institute’s Princeton Branch. Its proceedings will revolve around the crosstalk between tumor and systemic metabolism, with an emphasis on how cancers exploit and engineer both to support their growth, thwart immune surveillance and resist therapy. Presentations and discussions will also cover how the metabolic health of the host influences these processes and how information gleaned from the metabolic chatter between tumor and host might be harnessed for cancer prevention and therapy. Finally, talks will address the application of machine learning and artificial intelligence to extract useful information from the daunting mass of biochemical data typically generated by metabolomics studies.
Ludwig Institute Scientific Advisor Karen Vousden of The Francis Crick Institute in London will be giving the keynote address. Other invited speakers include authorities on various aspects of cancer metabolism, metabolomics, the tumor microenvironment and immunology.
Merit scholarships to defray the costs of attendance are available to qualifying applicants and the meeting welcomes submissions for small talks and posters on related research.
For more, visit the Ludwig Cancer Research website or browse the dedicated website.
Some key deadlines to keep in mind:
Scholarship deadline: November 12, 2026
Short talk abstract deadline: November 12, 2026
Early registration deadline: January 7, 2027
Poster abstract deadline: February 16, 2027
# # #
About Ludwig Cancer Research
Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer research and landmark discovery for more than 50 years. Ludwig combines basic science with the translation and clinical evaluation of its discoveries to accelerate the development of new cancer diagnostics, therapies and prevention strategies. Since 1971, Ludwig has invested nearly $3 billion in life-changing science through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers. To learn more, visit www.ludwigcancerresearch.org.
For additional information please contact communications@ludwigcancerresearch.org.